This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Oxford spinout Brainomix is revolutionising stroke care through AI

This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by a University of Oxford spinout company are ensuring that more stroke patients will receive better care and outcomes.

It’s no coincidence that the best-known acronym for spotting signs of a stroke urges FAST action. Every second counts, not least for the clinicians making crucial decisions about diagnosis and treatment.

Brainomix is a digital health company which spun out of the University’s preclinical stroke lab, part of the Nuffield Department of Clinical Neurosciences, in 2010. It was co-founded by Dr Michalis Papadakis, who now works full-time as the company’s CEO.

The company has developed state-of-the-art AI algorithms to help doctors make quick, accurate decisions for patients. Its e-Stroke platform analyses images from simple CT scans, providing detailed real-time information – available to view remotely – on the extent and nature of damage to the brain.

Read the full story on the University of Oxford website

Health Innovation Oxford and Thames Valley provided support for the introduction of e-stroke as seen in our case study here.

News Categories: Education and Training Innovation Healthcare Research